RORC and breast cancer: Consistent with the distinct function of RORγ in TNBC revealed by our genetic approach, the two RORγ antagonists displayed strong growth inhibition in most of the human TNBC cells and the highly metastatic mouse mammary tumor cells (4T1 and MET-1) (Fig. 2e).